Literature DB >> 8428930

Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system.

A Annweiler1, S Zwilling, R A Hipskind, T Wirth.   

Abstract

The transactivation potential of several isoforms of the lymphoid-specific transcription factor Oct2 has been analyzed using in vitro transcription. Oct2 can stimulate transcription in B-cell nuclear extracts and in HeLa nuclear extracts depleted of the ubiquitous factor Oct1 by wheat germ lectin affinity chromatography. Activity is observed from both natural and synthetic promoters containing single or multiple copies of the octamer motif ATGCAAAT. Multimerization of this motif does not result in a synergistic transcriptional stimulation, but rather leads to a linear increase in activity. To analyze the various Oct2 isoforms, they were overexpressed in HeLa cells using recombinant vaccinia virus. Although all the isoforms bind similarly to the octamer sequence, they show clear differences in their ability to transactivate transcription. This ranges from a 2-fold stimulation for Oct2.3 to the almost 20-fold effect of the most potent variant Oct2.5. In general the relative activity of the isoforms in vitro reflects that observed in vivo in cotransfection experiments. Interestingly the ubiquitous factor Oct1 is also an efficient activator of transcription in vitro, but only from promoters with multiple octamer motifs. Sarkosyl inhibition studies suggest that both Oct1 and Oct2 function in vitro by stabilizing preinitiation complexes without affecting the reinitiation rate of RNA polymerase II.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428930

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Transcription reinitiation rate: a special role for the TATA box.

Authors:  D Yean; J Gralla
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

2.  CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2.

Authors:  P Pfisterer; H König; J Hess; G Lipowsky; B Haendler; W D Schleuning; T Wirth
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

3.  The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP.

Authors:  S Zwilling; A Annweiler; T Wirth
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

4.  Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms.

Authors:  A Annweiler; S Zwilling; T Wirth
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

5.  Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma.

Authors:  Daniel L Di Bartolo; Elizabeth Hyjek; Shannon Keller; Ilaria Guasparri; Hongyu Deng; Ren Sun; Amy Chadburn; Daniel M Knowles; Ethel Cesarman
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

6.  Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB.

Authors:  Kerstin Mueller; Jasmin Quandt; Ralf B Marienfeld; Petra Weihrich; Katja Fiedler; Melina Claussnitzer; Helmut Laumen; Martin Vaeth; Friederike Berberich-Siebelt; Edgar Serfling; Thomas Wirth; Cornelia Brunner
Journal:  Nucleic Acids Res       Date:  2013-01-04       Impact factor: 16.971

7.  Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.

Authors:  P Pfisterer; A Annweiler; C Ullmer; L M Corcoran; T Wirth
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

8.  High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.

Authors:  S Zwilling; H König; T Wirth
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.